Back to Network
3
Shared Docs
3
Same-Page
4 / 3
Mentions
Document Mentions (3 shared documents)
3 mentions1 same-page
Page ?Same page
ll mails are also sent to our shared inbox [email protected] to avoid getting overlooked. This email is sent to you by Evalueserve on behalf of Deutsche Bankcont size=3> Diese email wurde Ihnen von Evalueserve im Auftrag der Deutschen Bank gesen=et For additional Deutsche Bank research, visit our web site: h
overlooked. This email is sent to you by Evalueserve on behalf of Deutsche Bankcont size=3> Diese email wurde Ihnen von Evalueserve im Auftrag der Deutschen Bank gesen=et For additional Deutsche Bank research, visit our web site: http://gm.db.com/equities Please refer to the disclaimer that applies to the re
om: EVS EquityFocus/db/dbcom=DBEMEA To: Date: 02/05/2014 05:01 AM Subject: DB: GILD.OQ - Robyn Karnauskas Classification: Public font size=3> Gilead Sciences (Buy, CP: $82.02, TP: $132.00, GILD.0Q, Robyn Karnauskas)</=> 4Q13 update: light taxes create more leverage for Sovaldi 4Q13 product revenues beat
2 mentions1 same-page
Page ?Same page
void getting overlooked. This email is sent to you by Evalueserve on behalf of Deutsche Bank Diese email wurde Ihnen von Evalueserve im Auftrag der Deutschen Bank gesendet For additional Deutsche Bank research, visit our web site: http://am.db.com/equities Please refer to the disclaimer that applies to the re
Classification: Public Gilead Sciences (Buy, CP: $82.02, TP: $132.00, GILD.OQ, Robyn Karnauskas) 4Q13 update: light taxes create more leverage for Sovaldi 4Q13 product revenues beat cons
2 mentions1 same-page
Page ?Same page
erlooked. This email is sent to you by Evalueserve on behalf of Deutsche Bank<=ont size="3"> Diese email wurde Ihnen von Evalueserve im Auftrag der Deutschen Bank gesen=et 2 EFTA_R1_01758240 EFTA02581644 For additional Deutsche Bank research, visit our web site: http://gm.db.com/equities Please refer to t
4 09:38 AM From: EVS EquityFocus/db/dbcom@DBEM=A To: Date: 02/05/2014 05:01 AM Subject: DB: GILD.OQ - Robyn Karnauska= Classification: Public Gilead Sciences (Buy, CP: $82.02, TP: $132.00, GILD.OQ, Robyn Karnauskas)</=> 4Q13 update: light taxes create more leverage for Sovaldi 4Q13 product revenues beat
Sponsored
Mutual Connections (11)
Entities connected to both Deutsche Bank and Gilead Sciences
Jeffrey Epstein
PERSON1,138 w/ Deutsche·4 w/ Gilead
Tazia Smith
PERSON198 w/ Deutsche·2 w/ Gilead
Bloomberg L.P.
ORGANIZATION130 w/ Deutsche·2 w/ Gilead
EV
Evalueserve
PERSON7 w/ Deutsche·3 w/ Gilead
SO
Sovaldi
PERSON3 w/ Deutsche·4 w/ Gilead
Atripla
ORGANIZATION3 w/ Deutsche·4 w/ Gilead
Generic Sustiva
ORGANIZATION3 w/ Deutsche·3 w/ Gilead
US & EU
ORGANIZATION3 w/ Deutsche·3 w/ Gilead
IE
Ihnen von Evalueserve
PERSON4 w/ Deutsche·2 w/ Gilead
RO
Robyn
PERSON2 w/ Deutsche·2 w/ Gilead
Sustiva
LOCATION2 w/ Deutsche·2 w/ Gilead